Способны ли препараты магния снижать риск рецидивирования мочекаменной болезни?

Способны ли препараты магния снижать риск рецидивирования мочекаменной болезни?

Автор: Голованов С.А., Сивков А.В.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Мочекаменная болезнь

Статья в выпуске: 4, 2011 года.

Бесплатный доступ

Мочекаменная болезнь, минеральный обмен, кальциевый уролитиаз, метафилактика, препараты магния

Короткий адрес: https://sciup.org/142188268

IDR: 142188268

Список литературы Способны ли препараты магния снижать риск рецидивирования мочекаменной болезни?

  • Slatopolky E. et al. In: Homeostasis of phosphate and other minerals. Massry S., Ritz E., Rapado A. (eds). Plenum Press. N.Y., 1978.
  • Chase L.R., Slatopolsky E. Secretion and metabolic efficiency of parathyroid hormone in patients with severe hypomagnesemia//J. Clin. Endocrinol. Metab. -1974 -38:P.363.
  • Connor T.B., Toskes P., Mahaffey J., Martin L.G., Williams J.B., Walser M. Parathyroid function during chronic magnesium deficiency//Johns Hopkins Med. J. 1972. Vol. 131, № 2. P. 100-117.
  • Rude R.K., Oldham S.B., Singer FR. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency//Clin. Endocrinol. (Oxf). 1976. Vol.5, № 3. P. 209-24.
  • Quamme G.A. Renal magnesium handling: new insights in understanding old problems//Kidney Int. 1997. Vol. 52, № 5. P1180-95.
  • al-Ghamdi S.M., Cameron E.C., Sutton R.A. Magnesium deficiency: pathophysiologic and clinical overview//Am. J. Kidney Dis. 1994. Vol.24, № 5. P737-52.
  • Friedman P.A. Renal calcium metabolism//In: The Kidney: Physiology and Physiopathology, 3rd Ed., edited by Giebisch G., Seldin D.W., Philadelphia, Lippincott Williams & Wilkins, 2000. P1749-1778.
  • Robertson W.G., Morgan D.B. The distribution of urinary calcium excretions in normal persons and stone-formers//Clin. Chim. Acta. 1972. Vol. 37. P. 503-508.
  • Mendel L., Benedict S. The paths of excretion for inorganic compounds: The excretion of magnesium//Am. J. Physiol. 1909. XXV. P. 1-22.
  • Chesley L.C., Tepper I. Some effects of magnesium loading upon renal excretion of magnesium and certain other electrolytes//J. Clin. Invest. 1958. Vol. 37. P. 1362-1372.
  • Cruikshank D.P., Pitkin R.M., Donnelly E., Reynolds WA. Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion//Obstet. Gynecol. 1981. Vol. 58. P. 430-434.
  • Suzuki K., Nonaka K., Kono N., Ichihara K., Fukumoto Y., Inui Y., Miyagawa J., Onishi T., Hayashi C., Tarui S. Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects//Calcif. Tissue Int. 1986. Vol. 39. P304-309.
  • Massry S.G., Ahumada J.J., Coburn J.W., Kleeman C.R. Effect of MgCl2 infusion on urinary Ca and Na during reduction in their filtered loads//Am. J. Physiol. 1970. Vol. 219. P. 881-885.
  • Le Grimellec C., Roinel N., Morel F. Simultaneous Mg, Ca, P, K, Na and Cl analysis in rat tubular fluid. II. During acute Mg plasma loading//Pflugers Arch. 1973. Vol. 340, № 3. P.197-210.
  • Carney S.L., Wong N.L., Quamme G.A., Dirks J.H. Effect of magnesium deficiency on renal magnesium and calcium transport in the rat//J. Clin. Invest. 1980. Vol. 65: P.180-188.
  • Amanzadeh J., Gitomer WL., Zerwekh J.E., Preisig P.A., Moe O.W, Pak C.Y., Levi M. Effect of high protein diet on stone-forming propensity and bone loss in rats//Kidney Int. 2003. Vol. 64. P. 2142-2149.
  • Breslau N.A., Brinkley L., Hill K.D., Pak C.Y. Relationship of animal protein rich diet to kidney stone formation and calcium metabolism//J. Clin. Endocrinol. Metab. 1988. Vol. 66. P.140-146.
  • Reddy S.T., Wang C.Y., Sakhaee K., Brinkley L., Pak C.Y. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism//Am. J. Kidney Dis. 2002. Vol. 40. P. 265-274.
  • Sakhaee K., Nicar M., Hill K., Pak C.Y. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts//Kidney Int. 1983. Vol. 24. P. 348-352.
  • Sebastian A., Harris S.T., Ottaway J.H., Todd K.M., Morris R.C. Jr. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate//N. Engl. J. Med. 1994. Vol. 330. P. 1776-1781.
  • Bindels R.J., Hartog A., Abrahamse S.L., Van Os C.H. Effects of pH on apical calcium entry and active calcium transport in rabbit cortical collecting system//Am. J. Physiol. 1994. Vol. 266. P620-627.
  • Yeh B.I, Yoon J., Huang C.L. On the role of pore helix in regulation of TRPV5 by extracellular protons//J. Membr. Biol. 2006. Vol. 212. P191-198.
  • Vennekens R., Prenen J., Hoenderop J.G., Bindels R.J., Droogmans G., Nilius B. Modulation of the epithelial Ca2+ channel ECaC by extracellular pH//Pflugers Arch. 2001. Vol. 442. P. 237-242.
  • Nilius B., Vennekens R., Prenen J., Hoenderop J.G., Droogmans G., Bindels R.J. The single pore residue Asp542 determines Ca2+ permeation and Mg2+ block of the epithelial Ca2+ channel//J. Biol. Chem. 2001. Vol. 276. P. 1020-1025.
  • Fetner C.D., Barilla D.E., Townsend J., Pak C.Y. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis//J.Urol. 1978. Vol. 120. P. P. 399-401.
  • Lindberg J.S., Zobitz M.M., Poindexter J.R., Pak C.Y. Magnesium bioavailability from magnesium citrate and magnesium oxide//J. Am. Coll. Nutr. 1990. Vol. 9. P.48-55.
  • Barilla D.E., Notz C., Kennedy D., Pak C.Y. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias: Effect of calcium and magnesium//Am. J. Med. 1978. Vol. 64. P. 579-585.
  • Zimmermann D.J., Voss S., von Unruh G.E., Hesse A. Importance of magnesium in absorption and excretion of oxalate//Urol. Int. 2005. Vol. 74. P. 262-267.
  • Guerra A., Meschi T., Allegri F., Prati B., Nouvenne A., Fiaccadori E., Borghi L. Concentrated urine and diluted urine: The effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load//Urol. Res. 2006. Vol. 34. P. 359-0364.
  • Schwille P.O., Schmiedl A., Herrmann U., Fan J., Gottlieb D., Manoharan M., Wipplinger J. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: Observations in patients with recurrent idiopathic calcium urolithiasis//Urol. Res. 1999. Vol. 27. P. 117-126.
  • Nicar M.J., Hill K., Pak C.Y. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro//J. Bone Miner. Res. 1987. Vol. 2. P. 215-220.
  • Mukai T., Howard J.E. Some observations on the calcification of rachitic cartilage by urine//Bull. Johns Hopkins Hosp. 1963. Vol. 112. P. 279-290.
  • Bastian H.P., Vahlensieck W The value of standard diet in urolithiasis//Eur. Urol. 1975. Vol.1, № 5. P. 235-237.
  • Gershoff S.N., Prien E.L. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones//Am. J. Clin. Nutr. 1967. Vol. 20. №5. P. 393-399.
  • Resnick M.I., Munday D., Boyce W.H. Magnesium excretion and calcium oxalate urolithiasis//Urology. 1982. Vol. 20, № 4. P. 385-389.
  • Morita N., Moriyama M., Miyazawa K., Tanaka T., Suzuki K. Evolution of strategy to measure urinary supersaturation//Hinyokika Kiyo. 2011. Vol. 57, № 1. P. 35-38.
  • Schwartz B.F., Bruce J., Leslie S., Stoller M.L. Rethinking the Role of Urinary Magnesium in Calcium Urolithiasis//Journal of Endourology. 2001. Vol. 15, № 3. P. 233-235.
  • Pak C.Y., Koenig K., Khan R., Haynes S., Padalino P. Physicochemical action of potassium -magnesium citrate in nephrolithiasis//J. Bone Miner. Res. 1992. Vol. 7. P.281-285.
  • Pak C.Y., Oh M.S., Baker S., Morris J.S. Effect of meal on the physiological and physicochemical actions of potassium citrate//J. Urol. 1991. Vol. 146. P. 803-805.
  • Ruml L.A., Gonzalez G., Taylor R., Wuermser L.A., Pak C.Y. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss//Am. J. Ther. 1999. Vol. 6. P. 45-50.
  • Ruml L.A., Pak C.Y. Effect of potassium magnesium citrate on thiazide induced hypokalemia and magnesium loss//Am. J. Kidney Dis. 1999. Vol. 34. P. 107-113.
  • Ruml L.A., Wuermser L.A., Poindexter J., Pak C.Y. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss//J. Clin. Pharmacol. 1998. Vol. 38. P. 1035-1041.
  • Sakhaee K., Alpern R., Jacobson H.R., Pak C.Y. Contrasting effects of various potassium salts on renal citrate excretion//J. Clin. Endocrinol. Metab. 1991. Vol. 72. P.396-400.
  • Sakhaee K., Maalouf N.M., Abrams S.A., Pak C.Y. Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women//J. Clin. Endocrinol. Metab. 2005. Vol. 90. P. 3528-3533.
  • Wabner C.L., Pak C.Y. Effect of orange juice consumption on urinary stone risk factors//J. Urol. 1993. Vol. 149. P. 1405-1408.
  • Wuermser L.A., Reilly C., Poindexter J.R., Sakhaee K., Pak C.Y. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia//Kidney Int. 2000. Vol. 57. P. 607-612.
  • Bonny O., Rubin F., Huang Ch.-L., Frawley WH., Pak C.Y.C. Mechanism of Urinary Calcium Regulation by Urinary Magnesium and pH//J. Am. Soc. Nephrol. 2008. Vol. 19. P. 1530-1537.
  • Ettinger B., Pak C.Y., Citron J.T., Thomas C., Adams-Huet B., Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis//J. Urol. 1997. Vol. 158, № 6. P. 2069-2073.
  • Schmiedl A., Schwille P.O. Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma//Magnes. Res. 2003. Vol.16, № 3. P. 192-205.
  • Schmiedl A., Schwille P.O. Magnesium status in idiopathic calcium urolithiasis-an orientational study in younger males//Eur. J. Clin. Chem. Clin. Biochem. 1996. Vol. 34, № 5. P. 393-400.
  • Hojgaard I., Fornander A.M., Nilsson M.A., Tiselius H.G. Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules//Urol. Res. 1999. Vol. 27, № 6. P. 417-425.
  • Türk C., Knoll T., Petrik A., Sarica K., Straub M., Seitz C. Guidelines on urolithiasis//European Association of Urology (EAU). 2011. 104 p.
  • Ettinger B., Citron J.T., Livermore B., Dolman L.I. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not//J. Urol. 1988. Vol. 139, № 4. P. 679-684.
  • Wilson D.R., Strauss A.L., Manuel M.A. Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis//Urol. Res. 1984. Vol. 12. P. 39-40.
  • Johansson G., Backman U., Danielson B.G., Fellström B., Ljunghall S., Wikström B. Effects of magnesium hydroxide in renal stone disease//J. Am. Coll. Nutr. 1982. Vol. 1, № 2. P. 179-185.
  • Prien E.L. Sr., Gershoff S.F. Magnesium oxide -pyridoxine therapy for recurrent calcium oxalate calculi//J. Urol. 1974. Vol. 112, № 4. P. 509-512.
  • Pearle M.S., Roehrborn C.G., Pak C.Y. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis//J. Endourol. 1999. Vol. 13, № 9. P. 679-685.
  • Berg W., Hesse A., Schneider H.J. A contribution to the formation mechanism of calcium oxalate urinary calculi. III. On the role of magnesium in the formation of oxalate calculi//Urol. Res. 1976. Vol. 4. P.161-167.
  • Elliot J.S., Ribeiro M.E. The effect of varying concentrations of calcium and magnesium upon calcium oxalate solubility//Invest. Urol. 1973. Vol. 10. P. 295-297.
  • Kok D.J., Papapoulos S.E., Blomen L.J., Bijvoet O.L. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro//Kidney Int. 1988. Vol. 34. P. 346-350.
  • Robertson W.G., Scurr D.S. Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine//J. Urol. 1986. Vol. 135. P. 1322-1326.
  • Su C.J., Shevock P.N., Khan S.R., Hackett R.L. Effect of magnesium on calcium oxalate urolithiasis//J. Urol. 1991. Vol. 145. P. 1092-1095.
  • Wunderlich W. Aspects of the influence of magnesium ions on the formation of calcium oxalate//Urol. Res. 1981. Vol. 9. P. 157-161.
  • Schwille P.O., Schmiedl A., Herrmann U., Fan J., Gottlieb D., Manoharan M., Wipplinger J. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis//Urol. Res. 1999. Vol. 27, № 2. P. 117-126.
Еще
Статья
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp